Peter Shields
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Evaluation of Canakinumab in High-Risk Former-Smokers (NCT06038526) | Peter Shields | 2024-03-11 |
Track Peter Shields automatically
Every clearance here is in the API, with alerts when new ones post.